Document is current
Any future updates will be listed below
-
Authors
Couce-Sánchez, Manuel https://orcid.org/0000-0002-2183-3824
Dal Santo, Francesco https://orcid.org/0000-0002-9879-6443
González-Blanco, Leticia https://orcid.org/0000-0001-6238-4773
Paniagua, Gonzalo
Rodríguez-Revuelta, Julia
Sáiz, Pilar A. https://orcid.org/0000-0002-5705-4523
García-Portilla, M. Paz https://orcid.org/0000-0003-3643-1622
- License Information
-
More Information
Article History
Received: 19 August 2025
Accepted: 16 October 2025
First Online: 27 November 2025
Competing interests
: L.G.B. has been a consultant to and/or has received lecture fees/grants from the Spanish Foundation of Psychiatry and Mental Health, Otsuka, Lundbeck, Johnson & Johnson, Casen Recordati, Angelini and Pfizer. G.P. has been a consultant to and/or has received honoraria or grants from Adamed, Alter Medica, Angelini Pharma, Johnson & Johnson, Lundbeck, Otsuka and Viatris España. P.A.S. has been a consultant to and/or has received honoraria or grants from Adamed, Alter Medica, Angelini Pharma, CIBERSAM, Ethypharm Digital Therapy, European Commission, Government of the Principality of Asturias, Instituto de Salud Carlos III, Johnson & Johnson, Lundbeck, Otsuka, Pfizer, Plan Nacional Sobre Drogas, Rovi, Servier and Viatris España. M.P.G.P. has been a consultant to and/or has received honoraria/grants from Angelini, Otsuka-Lundbeck Alliance, Instituto de Salud Carlos III, Janssen-Cilag, Lundbeck, Otsuka, and Pfizer. The other has no competing interests. All other authors declare that they have no conflicts of interest related to the current work.
